Project Grant R35GM166309
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $123,147 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) on May 13, 2026, with completion scheduled for April 30, 2028. This Project Grant funds fundamental research to illuminate jumbophage infection mechanisms, specifically examining how large bacteriophages (FKZ-like jumbophages with genomes exceeding 200...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Trustees of Boston University $437,036 under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on bacterial glycoconjugate biosynthesis. The award, initiated June 1, 2026 and extending through May 31, 2031, funds genomic enzymology research to decipher bacterial membrane-associated glycan assembly mechanisms. The project focuses on identifying...
- Federal Project Grant Award Summary Rochester Institute of Technology received a $186,354 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2029. This award supports a comprehensive research initiative to elucidate the roles of protein glycosylation in prokaryotes through functional glycoproteomics. The research employs an interdisciplinary...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $532,500 Project Grant to Sacramento State Sponsored Research, effective September 1, 2025, through August 31, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds fundamental research examining the function and evolution of bacterial strains within the human gut microbiota, with particular focus on Paraclostridium bifermentans and its role in...
- Federal Project Grant Award Summary New York University received a $421,737 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 10, 2026, with completion targeted for February 28, 2031. The award funds research to develop data-driven, predictive biophysical models that characterize the molecular mechanisms underlying cellular quiescence—the non-growing physiological states...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Washington University $804,800 under the Biomedical Research and Research Training program (CFDA 93.859) on August 5, 2025, to support investigator-initiated basic research through May 31, 2030. The award funds a multidisciplinary research program investigating the metabolic and regulatory mechanisms controlling antibiotic production in filamentous actinobacteria, with the objective of...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard College's Office for Sponsored Programs a $508,111 Project Grant (CFDA 93.859: Biomedical Research and Research Training) effective May 1, 2026, through February 28, 2031. The award supports investigator-initiated basic research focused on uncovering the molecular mechanisms and selectivity determinants of bacterial membrane proteins that mediate critical cellular processes including...
- Federal Project Grant Award Summary The University of Washington received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. This award funds fundamental research investigating the molecular coordination between two critical second messenger signaling pathways—cyclic diguanylate monophosphate (c-di-GMP) and cyclic adenosine...
- Federal Grant Award Summary Oregon State University received a $408,375 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 18, 2025, with completion targeted for July 31, 2030. The project, titled "Uncovering the Rules Governing Mobile Genetic Element Spread," focuses on characterizing how mobile genetic elements (MGEs)—including plasmids and integrative conjugative...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $441,375 to the University of California, Berkeley, effective April 1, 2026, through March 31, 2031. This five-year Project Grant supports fundamental research into the cellular and developmental mechanisms governing animal responses to intracellular beneficial microbes. The research utilizes the small sea anemone...
The National Institute of General Medical Sciences (NIGMS) awarded Health Research, Inc. Wadsworth Center a $386,003 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective August 1, 2026, through June 30, 2031. This award supports fundamental research investigating mechanisms of bacterial defense against conjugative plasmids and their phages, with specific focus on understanding how bacteria resist plasmid acquisition and viral infection. The research addresses a critical public health challenge by elucidating the molecular basis of plasmid-dependent phage (PDP) host range and identifying novel defense systems that bacteria employ at the plasmid-phage interface. The project deliverables encompass three integrated research objectives: (1) molecular dissection of the plasmid defense system CPDA in Pseudomonas aeruginosa to characterize plasmid transfer detection and blocking mechanisms; (2) determination of PDP host range molecular basis through comparative genomics and evolutionary experiments; and (3) discovery of new bacterial defenses through unbiased functional metagenomic screening. The research employs integrated methodologies including genetics, biochemistry, imaging, and metagenomics to uncover defense mechanisms that cannot be predicted from genomic sequence analysis alone. These findings are expected to advance fundamental understanding of bacterial-phage-plasmid interactions and contribute to strategies for controlling antibiotic resistance dissemination.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $386.0k | 7/7/26 |